Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joachim Petit

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
ACS Combinatorial Science|February 15, 2012
Concise one-pot preparation of unique bis-pyrrolidinone tetrazolesSteven Gunawan, Joachim Petit, Christopher Hulme
Bioorganic & Medicinal Chemistry|January 7, 2012
Softening the Rule of Five--where to draw the line?Joachim Petit, Nathalie Meurice, Christine Kaiser, et al.
Chemical Biology & Drug Design|August 3, 2006
Hierarchical strategy for identifying active chemotype classes in compound databasesJosé Luis Medina-Franco, Joachim Petit, Gerald M Maggiora
Molecular Informatics|August 3, 2016
Rough Set Theory as an Interpretable Method for Predicting the Inhibition of Cytochrome P450 1A2 and 2D6Julien Burton, Joachim Petit, Emeric Danloy, et al.
Plos One|November 28, 2012
Identification of small molecule inhibitors of PTPσ through an integrative virtual and biochemical approachKatie R Martin, Pooja Narang, Yong Xu, et al.
Chemical Biology & Drug Design|March 25, 2010
Chemogenomic analysis identifies Macbecin II as a compound specific for SMAD4-negative colon cancer cellsChristine Kaiser, Nathalie Meurice, Irma M Gonzales, et al.
Frontiers in Oncology|June 1, 2022
Single-Cell Proteomics and Tumor RNAseq Identify Novel Pathways Associated With Clofazimine Sensitivity in PI- and IMiD- Resistant Myeloma, and Putative Stem-Like CellsHarish Kumar, Suman Mazumder, Neeraj Sharma, et al.
Molecular Cancer Therapeutics|March 5, 2024
Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate CancerAdam M Kase, Justyna Gleba, James L Miller, et al.
Hepatology (Baltimore, Md.)|September 2, 2022
Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancersBolni Marius Nagalo, Yumei Zhou, Emilien J Loeuillard, et al.
JCO Precision Oncology|June 6, 2022
Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated With Poor Outcomes in Advanced Biliary Cancers Treated With Platinum-Based ChemotherapyPedro Luiz Serrano Uson Junior, Umair Majeed, Jun Yin, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
ACS Combinatorial Science|February 15, 2012
Concise one-pot preparation of unique bis-pyrrolidinone tetrazolesSteven Gunawan, Joachim Petit, Christopher Hulme
Bioorganic & Medicinal Chemistry|January 7, 2012
Softening the Rule of Five--where to draw the line?Joachim Petit, Nathalie Meurice, Christine Kaiser, et al.
Chemical Biology & Drug Design|August 3, 2006
Hierarchical strategy for identifying active chemotype classes in compound databasesJosé Luis Medina-Franco, Joachim Petit, Gerald M Maggiora
Molecular Informatics|August 3, 2016
Rough Set Theory as an Interpretable Method for Predicting the Inhibition of Cytochrome P450 1A2 and 2D6Julien Burton, Joachim Petit, Emeric Danloy, et al.
Plos One|November 28, 2012
Identification of small molecule inhibitors of PTPσ through an integrative virtual and biochemical approachKatie R Martin, Pooja Narang, Yong Xu, et al.
Chemical Biology & Drug Design|March 25, 2010
Chemogenomic analysis identifies Macbecin II as a compound specific for SMAD4-negative colon cancer cellsChristine Kaiser, Nathalie Meurice, Irma M Gonzales, et al.
Frontiers in Oncology|June 1, 2022
Single-Cell Proteomics and Tumor RNAseq Identify Novel Pathways Associated With Clofazimine Sensitivity in PI- and IMiD- Resistant Myeloma, and Putative Stem-Like CellsHarish Kumar, Suman Mazumder, Neeraj Sharma, et al.
Molecular Cancer Therapeutics|March 5, 2024
Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate CancerAdam M Kase, Justyna Gleba, James L Miller, et al.
Hepatology (Baltimore, Md.)|September 2, 2022
Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancersBolni Marius Nagalo, Yumei Zhou, Emilien J Loeuillard, et al.
JCO Precision Oncology|June 6, 2022
Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated With Poor Outcomes in Advanced Biliary Cancers Treated With Platinum-Based ChemotherapyPedro Luiz Serrano Uson Junior, Umair Majeed, Jun Yin, et al.
Pageof 2